{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:37:38Z","timestamp":1794710258005,"version":"4.9.1"},"reference-count":23,"publisher":"Wiley","issue":"s4","license":[{"start":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T00:00:00Z","timestamp":1219881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Dermatomycoses are contagious superficial fungal infections, which are highly prevalent in developed and developing countries. Caused by a range of <jats:italic>Epidermophyton<\/jats:italic>, <jats:italic>Microsporum<\/jats:italic> and <jats:italic>Trichophyton<\/jats:italic> species, dermatomycoses manifest on glabrous skin as \u2018ringworm\u2019, an annular scaly lesion with a variable inflammatory component. Itch is the chief subjective symptom, particularly in tinea cruris. Unless lesions are extensive or resistant to local therapy, dermatomycoses of glabrous skin are treated with topical antifungal agents, such as imidazoles and allylamines. Studies show, however, that the addition of a topical corticosteroid to imidazole therapy increases the bioavailability and prolongs the activity of the antimycotic, while rapidly reducing inflammatory symptoms. Travocort<jats:sup>\u00ae<\/jats:sup> is a combination of 1% isoconazole nitrate (ISN), a broad\u2010spectrum imidazole with established antimicrobial activity and antimycotic efficacy, and 0.1% diflucortolone valerate (DFV), a potent topical corticosteroid with low systemic absorption and therefore a low risk of systemic glucocorticoid side\u2010effects. In randomised, double\u2010blind controlled clinical trials, Travocort<jats:sup>\u00ae<\/jats:sup> therapy showed a more rapid onset of action, faster relief of itch and other inflammatory symptoms, improved overall therapeutic benefits and better mycological cure rate during the first 2\u2003weeks of treatment compared with ISN monotherapy. Travocort<jats:sup>\u00ae<\/jats:sup> is well tolerated and, because of prolonged ISN retention in the skin, provides antifungal protection against reinfection for some weeks after therapy.<\/jats:p>","DOI":"10.1111\/j.1439-0507.2008.01615.x","type":"journal-article","created":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T15:53:29Z","timestamp":1219938809000},"page":"16-26","source":"Crossref","is-referenced-by-count":48,"title":["The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses"],"prefix":"10.1111","volume":"51","author":[{"given":"Blanka","family":"Havlickova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,8,28]]},"reference":[{"key":"e_1_2_17_2_2","first-page":"163","article-title":"Diagnosis and management of common tinea infections","volume":"58","author":"Nobel SM","year":"1998","journal-title":"Am Fam Physician"},{"key":"e_1_2_17_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/13693780601070107"},{"key":"e_1_2_17_4_2","first-page":"707","volume-title":"Disease Control Priorities in Developing Countries","author":"Hay R","year":"2006"},{"key":"e_1_2_17_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)81262-5"},{"key":"e_1_2_17_6_2","first-page":"1989","volume-title":"Dermatology in General Medicine","author":"Nelson MM","year":"2003"},{"key":"e_1_2_17_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2008.03518.x"},{"key":"e_1_2_17_8_2","first-page":"2339","volume-title":"Dermatology in General Medicine","author":"Fitzpatrick JE","year":"2003"},{"key":"e_1_2_17_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1396-0296.2004.04055.x"},{"key":"e_1_2_17_10_2","volume-title":"Investigations with an Antimycotic\/Corticoid Combination Compared to Plain Antimycotic Preparations","author":"Hoppe G","year":"1984"},{"key":"e_1_2_17_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12521036"},{"key":"e_1_2_17_12_2","first-page":"1344","article-title":"Microbiological studies with isoconazole nitrate, a broad\u2010spectrum antimycotic from the group of imidazole derivatives","volume":"29","author":"Kessler H\u2010J","year":"1979","journal-title":"Drug Res"},{"key":"e_1_2_17_13_2","first-page":"377","article-title":"Once daily administration of isoconazole as a cream, solution and spray: comparative studies of patients with dermatomycoses","volume":"63","author":"Herms E","year":"1988","journal-title":"Z Hautkr"},{"key":"e_1_2_17_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1994.tb00283.x"},{"key":"e_1_2_17_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00472565"},{"key":"e_1_2_17_16_2","first-page":"21","article-title":"Bioavailability of isoconazole in the skin","volume":"22","author":"T\u00e4uber U","year":"1979","journal-title":"Mykosen"},{"key":"e_1_2_17_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1986.tb00476.x"},{"key":"e_1_2_17_18_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198800365-00006"},{"key":"e_1_2_17_19_2","first-page":"1492","article-title":"Comparative studies in man on the percutaneous absorption of diflucortolone valerate, betamethasone\u201017\u2010valerate, beclomethasone dipropionate and fluocinolone acetonide","volume":"26","author":"Tauber VU","year":"1976","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_17_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1981.tb01712.x"},{"key":"e_1_2_17_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1979.tb01738.x"},{"key":"e_1_2_17_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1980.tb01777.x"},{"key":"e_1_2_17_23_2","volume-title":"Travocort\u00ae\/Travogen\u00ae Cream. Multicentre Clinical Studies of 525 Patients With Inflammatory Dermatomycoses in 12 Dermatological Practices in Germany","author":"Schropl F","year":"1981"},{"key":"e_1_2_17_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1980.tb02586.x"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.2008.01615.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1439-0507.2008.01615.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T03:54:17Z","timestamp":1694663657000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.2008.01615.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,28]]},"references-count":23,"journal-issue":{"issue":"s4","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1439-0507.2008.01615.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.2008.01615.x","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,28]]}}}